With Plasma-Safe-SeqS, 100% of the starting molecules are analyzed, which isn’t always the case with other methods or technologies. This chart shows that with Plasma-Safe-SeqS, the input molecules are not lost along the sequencing process like they commonly can be with other methods or technologies. The chart shows the sample input of benign molecules and mutant molecules remain intact throughout sample amplification, multiplexing, dilution, purification, and quantification. The second part of the chart shows that 40% of molecules could be lost during sample preparation prior to ligation/hybrid-capture based next-generation sequencing (or NGS), which could lead to a false negative or inaccurate analysis.
General help line:
For more information on the data in the table, contact us at email@example.com